Lobbying client

GEOVAX LABS INC

Biotechnology company developing vaccines

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
12
Filed by
2
Reported in-house
—
Reported by firms
$125,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2009 to 2016

Filings

12 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2016
STRATEGIC MARKETING INNOVATIONS — reported
3rd Quarter - Reportreplaced
3rd Quarter 2016
STRATEGIC MARKETING INNOVATIONS — reported
2nd Quarter - Report
2nd Quarter 2016
STRATEGIC MARKETING INNOVATIONS $5,000 reported
Registration
2nd Quarter 2016
STRATEGIC MARKETING INNOVATIONS — reported
3rd Quarter - Termination (No Activity)
3rd Quarter 2010
WOMBLE CARLYLE SANDRIDGE & RICE, LLP — reported
2nd Quarter - Report
2nd Quarter 2010
WOMBLE CARLYLE SANDRIDGE & RICE, LLP $30,000 reported
1st Quarter - Report
1st Quarter 2010
WOMBLE CARLYLE SANDRIDGE & RICE, LLP $30,000 reported
4th Quarter - Report
4th Quarter 2009
WOMBLE CARLYLE SANDRIDGE & RICE, LLP $30,000 reported
3rd Quarter - Amendment
3rd Quarter 2009
WOMBLE CARLYLE SANDRIDGE & RICE, LLP $30,000 reported
3rd Quarter - Reportreplaced
3rd Quarter 2009
WOMBLE CARLYLE SANDRIDGE & RICE, LLP $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

Issues lobbied

How many report sections named each issue, counting the current version of each report.

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.